Associated Papers
Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms.
Morishita S et al.
International Journal of Molecular Sciences, 2023
ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.
Shi Z et al.
Haematologica, 2023
Clinical and molecular characteristics of forty Chinese children with essential thrombocythemia: A single-center, retrospective analysis.
Zhang L et al.
British Journal of Haematology, 2023
Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia.
Lin D et al.
Bmc Medical Genomics, 2023
Expression properties, structural features and functional analysis of CALR E381A in MPN patients.
Xu K et al.
American Journal of Translational Research, 2023
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
Cheng WY et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.
Yu H et al.
Frontiers in Oncology, 2022
Mapping human calreticulin regions important for structural stability.
Čiplys E et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics, 2021
Calreticulin Mutation Survey by High Resolution Melting Method Associated with Unique Presentations in Essential Thrombocythemic Patients.
Liu YC et al.
Mediterranean Journal of Hematology and Infectious Diseases, 2020
Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.
Fang Y et al.
Frontiers in Oncology, 2020
Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P et al.
Nature, 2019
A novel somatic CALR mutation in essential thrombocythemia and effective response to interferon-alfa-2b therapy.
Zhang X et al.
Blood Cells, Molecules & Diseases, 2018
Mutation profiling by targeted sequencing of "triple-negative" essential thrombocythaemia patients.
Ju M et al.
British Journal of Haematology, 2018
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.
Lim KH et al.
Oncotarget, 2017
Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2016
Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).
Luo W et al.
Stem Cell Investigation, 2015